FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/05/2022
Voltar para busca
Dado oficial do USPTO
FEMCHECK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
FEMCHECK
ST13
US500000079299178Classe
5, 9, 35, 42
Pedido
79299178
Registro
6541669
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
16/05/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 35, 42
Data de depósito
26/05/2020
Data de registro
02/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/11/2021
Última transação
02/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Palmerston North, NZ
Examinador
CAYSIDO, REBECCA
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SCIENCE HAVEN LIMITED
Representantes
Kazuyo Morita Holland & Hart LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females
Classe 9
Downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; Downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females
Classe 35
Retail and wholesale store services for non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; online advertising and marketing services in relation to the aforementioned goods
Classe 42
Software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; software as a service (SAAS) services featuring software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/04/2022
FIMP
FINAL DISPOSITION PROCESSED
22/04/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/08/2021
PUBO
PUBLISHED FOR OPPOSITION
17/08/2021
GPNX
NOTIFICATION PROCESSED BY IB
15/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28/07/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
28/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/07/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
13/07/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/07/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
13/07/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/06/2021
ATRV
ATTORNEY REVIEW COMPLETED
23/03/2021
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
23/03/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
28/02/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/02/2021
RFNT
REFUSAL PROCESSED BY IB
11/01/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/12/2020
RFRR
REFUSAL PROCESSED BY MPU
16/12/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/12/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/12/2020
CNRT
NON-FINAL ACTION WRITTEN
07/12/2020
DOCK
ASSIGNED TO EXAMINER
04/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FEMCHECK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.